HPLC tells you how much of something you have. Mass spectrometry tells you what it is. The quality of a research peptide rests on the fact that these are different questions and both need to be answered.
What this covers: How HPLC separates a peptide from its impurities, how mass spectrometry confirms identity, and how the "purity %" number on a Certificate of Analysis is actually calculated.
Why it matters: A "99% pure" claim only has meaning if you know what the 99% is. Purity and identity are different questions and both analytical techniques are needed.
Key takeaways: HPLC answers "how homogeneous" · Mass spec answers "what is it" · Area-percent purity is a proxy, not a mass measurement · Real COAs show the raw traces
Who this is for: Researchers and buyers who want to understand what is behind the headline numbers on a peptide COA.
Why two techniques are needed
A common shorthand in the research peptide world is "99% pure." The number sounds precise, and in a sense it is, but it hides an important subtlety: a purity number, on its own, does not tell you what is 99% pure. You could in principle have a vial containing a single, cleanly synthesized, 99% pure compound that is not the compound you ordered. Purity is a statement about homogeneity. Identity is a different statement about chemistry. A research-grade analytical report needs to address both.
The two techniques that between them answer the two questions are High-Performance Liquid Chromatography (HPLC) — which measures purity by separating the sample and quantifying the main component against its impurities — and Mass Spectrometry (MS), which measures identity by determining the molecular weight of the main component and comparing it to the theoretical mass calculated from the intended peptide sequence. Neither technique substitutes for the other. Both are needed.
High-Performance Liquid Chromatography (HPLC)
How it works
HPLC is a separation technique. A small, dissolved sample of the peptide is injected into a stream of solvent (the mobile phase, the liquid that carries the sample) and pushed under high pressure through a stainless-steel column packed with a chemically functionalized stationary phase (the solid material the molecules temporarily stick to). Different molecules in the sample partition between the mobile and stationary phases to different degrees depending on their chemical properties, which causes them to emerge from the column at different times. A detector placed at the outlet records the arrival of each component as a function of time, producing a chromatogram.
Reverse-phase HPLC for peptides
For peptide analysis the dominant variant is reverse-phase HPLC, in which the stationary phase is a non-polar hydrocarbon-coated silica (most commonly C18 — an octadecyl chain, 18 carbons long) and the mobile phase is a mixture of water and an organic solvent like acetonitrile, typically with a small amount of trifluoroacetic acid as a mobile-phase modifier. Under these conditions, more hydrophobic (water-repelling) peptides interact more strongly with the stationary phase and elute (come off the column) later than more hydrophilic (water-loving) peptides. By running a gradient — gradually increasing the organic content of the mobile phase during the run — a wide range of peptides can be resolved into distinct, sharp peaks.
UV detection
The detector most commonly paired with reverse-phase HPLC for peptide work is a UV absorbance detector, typically monitoring at 214 nm, where the peptide bond itself absorbs, or at 280 nm, where aromatic residues (tryptophan, tyrosine, phenylalanine) absorb. The 214 nm channel is the more general-purpose choice because every peptide bond absorbs there regardless of residue composition. Other detection methods — diode-array, evaporative light scattering, charged aerosol — exist and have their places, but UV at 214 nm is the industry baseline for routine peptide purity analysis.
Reading a chromatogram
A chromatogram is read as a time-series trace, with time on the x-axis (the retention time) and detector signal on the y-axis. Each peak represents a compound emerging from the column. For a well-purified synthetic peptide, the trace shows one dominant peak — tall, symmetrical, sitting at its characteristic retention time — with a flat baseline before and after. Small additional peaks may be present, representing low-level impurities.
Several features distinguish a healthy chromatogram from a suspicious one:
- Peak shape. A clean, narrow, symmetrical peak suggests good chromatography. Broad, tailing, or fronted peaks can indicate column degradation, sample overload, or compound heterogeneity.
- Baseline quality. A flat, quiet baseline before and after the main peak is the expected background. Rising or noisy baselines suggest instrument or sample issues.
- Resolution from impurities. Impurity peaks should be separated from the main peak with a return to baseline between them, not merging into shoulders.
- Retention time at expected value. For a known compound under standardized conditions, the retention time is a characteristic fingerprint.
Area-percent and what "98% pure" actually means
The purity figure reported on a COA is almost always an area-percent calculation. For each peak on the chromatogram, the software integrates the area under the curve — the detector signal multiplied by time. The area of the main peak is divided by the sum of the areas of all peaks, and the result is expressed as a percentage.
Written as a simple formula, this is: purity (%) = (area of main peak / sum of all peak areas) × 100.
A result of "98.5% purity" therefore means that 98.5% of the UV-absorbing material that eluted from the column during the analytical run was associated with the main peak. It does not mean that 98.5% of the mass in the vial is the target compound. Water, salt, residual solvent, and any compound that does not absorb significantly at 214 nm will not contribute to the area-percent calculation at all.
This is not a criticism of the technique — it is simply a matter of reading the number accurately. For a lyophilized (freeze-dried) peptide that has been properly desalted and dried, the area-percent number is a meaningful proxy for mass purity of the target compound. For a poorly-prepared sample, it is less meaningful. The assumption does work for well-prepared research-grade peptides and breaks down for sloppy ones.
Common impurities in synthetic peptide production
Synthetic peptides are generally made by solid-phase peptide synthesis, in which the peptide is assembled one residue at a time on a resin support, with each coupling followed by a deprotection step. The chemistry is mature and usually efficient, but no coupling is perfectly quantitative, and a number of characteristic side-products show up in crude peptide mixtures.
- Deletion sequences. A peptide missing one or more residues because a coupling step failed. Deletion peptides elute at different retention times from the target and are resolved by HPLC purification.
- Truncated sequences. Chains that stopped early because a subsequent coupling failed entirely.
- Diastereomers. Peptides containing a D-amino acid where an L-amino acid was intended, typically produced by racemization during coupling.
- Oxidation products. Methionine or cysteine residues oxidized during synthesis or workup.
- Acetylation or other side-chain modifications. Uncontrolled side reactions, typically at low levels.
Purification — typically by preparative reverse-phase HPLC — removes most of these impurities, and the analytical HPLC run on the final product is the verification that the purification did its job.
Mass Spectrometry (MS)
How it works
Mass spectrometry measures molecular mass by ionizing the sample (giving molecules an electrical charge) and separating the resulting ions according to their mass-to-charge ratio (m/z). The instrument has three core components: an ion source, which converts molecules in solution into gas-phase ions; a mass analyzer, which separates ions by m/z; and a detector, which records the ions that arrive. The result is a mass spectrum: a plot of ion abundance against m/z.
Electrospray ionization (ESI)
The ion source most commonly used for peptide analysis is electrospray ionization (ESI). In an ESI source, the sample solution is sprayed through a fine needle held at high voltage, producing a mist of charged droplets. As the solvent evaporates, the droplets shrink and eventually release intact peptide ions into the gas phase. ESI is a gentle ionization method — it preserves the peptide in its intact molecular form, which is exactly what is needed for identity confirmation.
Peptides ionized by ESI typically carry multiple protons (charges), so a single peptide can produce several peaks in the mass spectrum corresponding to different charge states (+1, +2, +3, and so on). Software converts the observed m/z values back to a single deconvoluted mass representing the molecular weight of the neutral compound.
Expected mass vs. observed mass
A peptide's expected mass is calculated from its sequence. Each amino acid contributes its residue mass (the mass of the free amino acid minus the water lost when it joined the peptide chain). The total peptide mass is the sum of residue masses plus one water molecule (for the free N-terminus and C-terminus), with corrections for any terminal modifications such as N-terminal acetylation or C-terminal amidation.
The resulting number is the monoisotopic mass: the mass of the molecule in which all atoms are the most abundant naturally-occurring isotope. For small peptides, modern mass spectrometers can measure the observed mass to within a fraction of a dalton, so the comparison between calculated and observed mass is a sharp identity check.
A typical COA entry might read something like: "Expected mass: 1412.66 Da. Observed mass: 1412.65 Da. Match: confirmed." Researchers reading the document can verify the expected mass themselves from the published sequence — it is a reproducible calculation — and cross-check that the observed value matches.
Why identity matters (you cannot rely on HPLC alone)
It is worth spelling out why identity confirmation is not redundant with purity analysis. HPLC with UV detection measures homogeneity — how cleanly the sample is dominated by a single component — but it does not measure which component. Two different peptides with similar hydrophobicity and similar UV absorbance can elute at similar retention times and produce similar-looking peaks. A peak at the expected retention time on an HPLC chromatogram is consistent with the target compound, but it is not proof of identity on its own.
Mass spectrometry closes the gap because different peptides have different masses, and the match between the calculated and observed mass is specific in a way that retention time is not. A researcher who has both an HPLC purity of 99% and a mass spectrometry identity confirmation within 0.01 Da of the expected mass has strong joint evidence that the vial contains the intended compound at the intended purity.
Orthogonal methods
Beyond HPLC and MS, several other techniques are occasionally used to characterize research peptides, usually in specialized circumstances.
- Nuclear Magnetic Resonance (NMR). Provides detailed structural information and can confirm amino acid composition and connectivity. Used more often for novel compounds and research-grade reference materials than for routine batch release, because it is slower and more expensive than HPLC–MS.
- Amino acid analysis. The peptide is hydrolyzed to its free amino acids, which are then quantified individually. This technique confirms composition and is used to establish absolute peptide content, which HPLC area-percent does not measure directly.
- Capillary electrophoresis. A separation technique orthogonal to HPLC, sometimes used to cross-check purity by a different physical principle.
For routine research peptide characterization, HPLC paired with mass spectrometry answers the operational question of "is this the right compound, and how pure is it?" The other techniques are orthogonal confirmations rather than replacements.
Reading a professional COA from an independent lab
A well-constructed independent Certificate of Analysis will present, at minimum, the HPLC chromatogram, the purity number with the integration method disclosed, the mass spectrum or at least the observed mass deconvolution, the calculated expected mass for comparison, the batch number tied to the physical vial, and the analyst and laboratory identification. A researcher reading the document can verify the expected mass from the peptide sequence independently, inspect the chromatogram for the features described above, and satisfy themselves that the observed mass matches the calculated value.
A COA that reports only a headline purity number without the underlying chromatogram and mass spectrum is substantially less useful. It is not necessarily wrong — the underlying data may be entirely legitimate — but it does not allow independent verification of the kind that the documents exist to support.
Common mistakes in interpretation
A few recurring errors are worth naming explicitly, because they appear frequently in discussions of research peptide quality.
- Confusing purity with potency. Purity is a statement about the fraction of detected material that is the target compound. Potency is a statement about biological activity per unit mass. The two are related but not the same; a pure peptide can have reduced potency due to improper handling after synthesis, and HPLC cannot measure biological activity.
- Ignoring identity in favor of purity. A high purity number without a corresponding identity confirmation is an incomplete claim about the material. Identity is the more load-bearing piece of information.
- Trusting manufacturer COAs without independent verification. The manufacturer has an obvious commercial interest in favorable numbers. Independent laboratory reports are structurally more credible.
- Over-interpreting precision. Real HPLC purity measurements have variance; seeing "99.00%" on five batches in a row is not plausibly the output of an honest analytical process, and should be read as a red flag rather than a mark of consistency.
- Ignoring what is not tested. A COA that reports HPLC purity and mass spectrometry identity but omits endotoxin, heavy metals, and bioburden is not a complete picture of the material's suitability for research use.
This article is methodological. It describes how analytical techniques are used to characterize research-grade peptides and how their output should be read. It is not medical advice, does not endorse human use of any research chemical, and does not describe dosing, administration, or any application beyond laboratory reagent characterization.